{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:25:16Z","timestamp":1793413516453,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autosomal dominant polycystic kidney disease (ADPKD) is a common kidney disease caused by mutations in <jats:italic>PKD1<\/jats:italic> or <jats:italic>PKD2<\/jats:italic>. Metformin reduces cyst growth in mouse models of <jats:italic>PKD1<\/jats:italic>. However, metformin has not been studied in animal models of <jats:italic>PKD2<\/jats:italic>, and the cellular mechanism underlying its effectiveness is not entirely clear. This study investigated the effects of metformin on cyst formation in a zebrafish model of polycystin-2 deficiency resulting from morpholino knockdown of <jats:italic>pkd2<\/jats:italic>. We added metformin (2.5 to 20\u2009mM) to the embryo media between 4 and 48\u2009hours post fertilisation and observed pronephric cyst formation by using the <jats:italic>wt1b<\/jats:italic> promoter-driven GFP signal in <jats:italic>Tg<\/jats:italic>(<jats:italic>wt1b:GFP<\/jats:italic>) <jats:italic>pkd2<\/jats:italic> morphants. Metformin inhibited pronephric cyst formation by 42\u201361% compared with the untreated controls. Metformin also reduced the number of proliferating cells in the pronephric ducts, the degree of dorsal body curvature, and the infiltration of leukocytes surrounding the pronephros. Moreover, metformin treatment increased the phosphorylation of adenosine monophosphate-activated protein kinase (AMPK) and enhanced autophagy in the pronephros. Our data suggest that metformin reduces cyst formation through activation of the AMPK pathway and modulation of defective cellular events such as proliferation and autophagy. These results also imply that metformin could have therapeutic potential for ADPKD treatment.<\/jats:p>","DOI":"10.1038\/s41598-017-07300-x","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T14:45:10Z","timestamp":1501166710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency"],"prefix":"10.1038","volume":"7","author":[{"given":"Ming-Yang","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu-Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chieh","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Chung","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,2]]},"reference":[{"key":"7300_CR1","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1681\/ASN.2015050583","volume":"27","author":"CM Heyer","year":"2016","unstructured":"Heyer, C. M. et al. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol \n                           27, 2872\u20132884, doi:10.1681\/ASN.2015050583 (2016).","journal-title":"J Am Soc Nephrol"},{"key":"7300_CR2","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0140-6736(15)60907-2","volume":"385","author":"AC Ong","year":"2015","unstructured":"Ong, A. C., Devuyst, O., Knebelmann, B. & Walz, G. Autosomal dominant polycystic kidney disease: the changing face of clinical management. Lancet \n                           385, 1993\u20132002, doi:10.1016\/S0140-6736(15)60907-2 (2015).","journal-title":"Lancet"},{"key":"7300_CR3","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall, E. et al. Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol \n                           24, 1006\u20131013, doi:10.1681\/ASN.2012070650 (2013).","journal-title":"J Am Soc Nephrol"},{"key":"7300_CR4","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1681\/ASN.2013091026","volume":"25","author":"JJ Talbot","year":"2014","unstructured":"Talbot, J. J. et al. The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation. J Am Soc Nephrol \n                           25, 1737\u20131748, doi:10.1681\/ASN.2013091026 (2014).","journal-title":"J Am Soc Nephrol"},{"key":"7300_CR5","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1242\/jcs.02818","volume":"119","author":"L Geng","year":"2006","unstructured":"Geng, L. et al. Polycystin-2 traffics to cilia independently of polycystin-1 by using an N-terminal RVxP motif. J Cell Sci \n                           119, 1383\u20131395, doi:10.1242\/jcs.02818 (2006).","journal-title":"J Cell Sci"},{"key":"7300_CR6","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1681\/ASN.2006040412","volume":"17","author":"T Obara","year":"2006","unstructured":"Obara, T. et al. Polycystin-2 immunolocalization and function in zebrafish. J Am Soc Nephrol \n                           17, 2706\u20132718, doi:10.1681\/ASN.2006040412 (2006).","journal-title":"J Am Soc Nephrol"},{"key":"7300_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ki.2015.207","volume":"88","author":"AC Ong","year":"2015","unstructured":"Ong, A. C. & Harris, P. C. A polycystin-centric view of cyst formation and disease: the polycystins revisited. Kidney Int \n                           88, 699\u2013710, doi:10.1038\/ki.2015.207 (2015).","journal-title":"Kidney Int"},{"key":"7300_CR8","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1172\/JCI72272","volume":"124","author":"PC Harris","year":"2014","unstructured":"Harris, P. C. & Torres, V. E. Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. J Clin Invest \n                           124, 2315\u20132324, doi:10.1172\/JCI72272 (2014).","journal-title":"J Clin Invest"},{"key":"7300_CR9","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nm.3092","volume":"19","author":"I Rowe","year":"2013","unstructured":"Rowe, I. et al. Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat Med \n                           19, 488\u2013493, doi:10.1038\/nm.3092 (2013).","journal-title":"Nat Med"},{"key":"7300_CR10","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1172\/JCI80467","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen, L. et al. Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease. J Clin Invest \n                           125, 2399\u20132412, doi:10.1172\/JCI80467 (2015).","journal-title":"J Clin Invest"},{"key":"7300_CR11","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1056\/NEJMc1300762","volume":"368","author":"VE Torres","year":"2013","unstructured":"Torres, V. E., Gansevoort, R. T. & Czerwiec, F. S. Tolvaptan in autosomal dominant polycystic kidney disease. N Engl J Med \n                           368, 1259, doi:10.1056\/NEJMc1300762 (2013).","journal-title":"N Engl J Med"},{"key":"7300_CR12","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz, G. et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N Engl J Med \n                           363, 830\u2013840, doi:10.1056\/NEJMoa1003491 (2010).","journal-title":"N Engl J Med"},{"key":"7300_CR13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra, A. L. et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med \n                           363, 820\u2013829, doi:10.1056\/NEJMoa0907419 (2010).","journal-title":"N Engl J Med"},{"key":"7300_CR14","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest \n                           108, 1167\u20131174, doi:10.1172\/JCI13505 (2001).","journal-title":"J Clin Invest"},{"key":"7300_CR15","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1172\/JCI44145","volume":"121","author":"SA Wander","year":"2011","unstructured":"Wander, S. A., Hennessy, B. T. & Slingerland, J. M. Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy. J Clin Invest \n                           121, 1231\u20131241, doi:10.1172\/JCI44145 (2011).","journal-title":"J Clin Invest"},{"key":"7300_CR16","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1126\/science.1120781","volume":"310","author":"RJ Shaw","year":"2005","unstructured":"Shaw, R. J. et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science \n                           310, 1642\u20131646, doi:10.1126\/science.1120781 (2005).","journal-title":"Science"},{"key":"7300_CR17","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.2741\/3460","volume":"14","author":"B Viollet","year":"2009","unstructured":"Viollet, B. et al. Targeting the AMPK pathway for the treatment of Type 2 diabetes. Front Biosci (Landmark Ed) \n                           14, 3380\u20133400 (2009).","journal-title":"Front Biosci (Landmark Ed)"},{"key":"7300_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1042\/CS20110386","volume":"122","author":"B Viollet","year":"2012","unstructured":"Viollet, B. et al. Cellular and molecular mechanisms of metformin: an overview. Clin Sci (Lond) \n                           122, 253\u2013270, doi:10.1042\/CS20110386 (2012).","journal-title":"Clin Sci (Lond)"},{"key":"7300_CR19","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1476-5381.2010.01101.x","volume":"162","author":"HG Kim","year":"2011","unstructured":"Kim, H. G. et al. Metformin inhibits P-glycoprotein expression via the NF-kappaB pathway and CRE transcriptional activity through AMPK activation. Br J Pharmacol \n                           162, 1096\u20131108, doi:10.1111\/j.1476-5381.2010.01101.x (2011).","journal-title":"Br J Pharmacol"},{"key":"7300_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4111\/icu.2016.57.3.157","volume":"57","author":"RK Sayyid","year":"2016","unstructured":"Sayyid, R. K. & Fleshner, N. E. Potential role for metformin in urologic oncology. Investig Clin Urol \n                           57, 157\u2013164, doi:10.4111\/icu.2016.57.3.157 (2016).","journal-title":"Investig Clin Urol"},{"key":"7300_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nm.3596","volume":"20","author":"M Pollak","year":"2014","unstructured":"Pollak, M. Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment. Nat Med \n                           20, 591\u2013593, doi:10.1038\/nm.3596 (2014).","journal-title":"Nat Med"},{"key":"7300_CR22","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.mehy.2009.05.043","volume":"73","author":"MF McCarty","year":"2009","unstructured":"McCarty, M. F., Barroso-Aranda, J. & Contreras, F. Activation of AMP-activated kinase as a strategy for managing autosomal dominant polycystic kidney disease. Med Hypotheses \n                           73, 1008\u20131010, doi:10.1016\/j.mehy.2009.05.043 (2009).","journal-title":"Med Hypotheses"},{"key":"7300_CR23","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1073\/pnas.1011498108","volume":"108","author":"V Takiar","year":"2011","unstructured":"Takiar, V. et al. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc Natl Acad Sci USA \n                           108, 2462\u20132467, doi:10.1073\/pnas.1011498108 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"7300_CR24","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00424-013-1394-x","volume":"466","author":"D Mekahli","year":"2014","unstructured":"Mekahli, D. et al. Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin. Pflugers Arch \n                           466, 1591\u20131604, doi:10.1007\/s00424-013-1394-x (2014).","journal-title":"Pflugers Arch"},{"key":"7300_CR25","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1681\/ASN.2010070728","volume":"22","author":"MY Chang","year":"2011","unstructured":"Chang, M. Y. et al. Inhibition of the P2X7 receptor reduces cystogenesis in PKD. J Am Soc Nephrol \n                           22, 1696\u20131706, doi:10.1681\/ASN.2010070728 (2011).","journal-title":"J Am Soc Nephrol"},{"key":"7300_CR26","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1681\/ASN.2013101060","volume":"25","author":"S Le Corre","year":"2014","unstructured":"Le Corre, S., Eyre, D. & Drummond, I. A. Modulation of the secretory pathway rescues zebrafish polycystic kidney disease pathology. J Am Soc Nephrol \n                           25, 1749\u20131759, doi:10.1681\/ASN.2013101060 (2014).","journal-title":"J Am Soc Nephrol"},{"key":"7300_CR27","doi-asserted-by":"publisher","first-page":"E2363","DOI":"10.1073\/pnas.1517066113","volume":"113","author":"M Arif Pavel","year":"2016","unstructured":"Arif Pavel, M. et al. Function and regulation of TRPP2 ion channel revealed by a gain-of-function mutant. Proc Natl Acad Sci USA \n                           113, E2363\u20132372, doi:10.1073\/pnas.1517066113 (2016).","journal-title":"Proc Natl Acad Sci USA"},{"key":"7300_CR28","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1242\/dev.02827","volume":"134","author":"J Schottenfeld","year":"2007","unstructured":"Schottenfeld, J., Sullivan-Brown, J. & Burdine, R. D. Zebrafish curly up encodes a Pkd2 ortholog that restricts left-side-specific expression of southpaw. Development \n                           134, 1605\u20131615, doi:10.1242\/dev.02827 (2007).","journal-title":"Development"},{"key":"7300_CR29","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1242\/dev.01240","volume":"131","author":"Z Sun","year":"2004","unstructured":"Sun, Z. et al. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development \n                           131, 4085\u20134093, doi:10.1242\/dev.01240 (2004).","journal-title":"Development"},{"key":"7300_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1242\/dmm.003194","volume":"3","author":"S Mangos","year":"2010","unstructured":"Mangos, S. et al. The ADPKD genes pkd1a\/b and pkd2 regulate extracellular matrix formation. Dis Model Mech \n                           3, 354\u2013365, doi:10.1242\/dmm.003194 (2010).","journal-title":"Dis Model Mech"},{"key":"7300_CR31","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1242\/bio.20121016","volume":"1","author":"E Bubenshchikova","year":"2012","unstructured":"Bubenshchikova, E. et al. Wtip and Vangl2 are required for mitotic spindle orientation and cloaca morphogenesis. Biol Open \n                           1, 588\u2013596, doi:10.1242\/bio.20121016 (2012).","journal-title":"Biol Open"},{"key":"7300_CR32","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1093\/hmg\/ddr214","volume":"20","author":"K Slanchev","year":"2011","unstructured":"Slanchev, K., Putz, M., Schmitt, A., Kramer-Zucker, A. & Walz, G. Nephrocystin-4 is required for pronephric duct-dependent cloaca formation in zebrafish. Hum Mol Genet \n                           20, 3119\u20133128, doi:10.1093\/hmg\/ddr214 (2011).","journal-title":"Hum Mol Genet"},{"key":"7300_CR33","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1242\/dev.066340","volume":"138","author":"SC Rothschild","year":"2011","unstructured":"Rothschild, S. C., Francescatto, L., Drummond, I. A. & Tombes, R. M. CaMK-II is a PKD2 target that promotes pronephric kidney development and stabilizes cilia. Development \n                           138, 3387\u20133397, doi:10.1242\/dev.066340 (2011).","journal-title":"Development"},{"key":"7300_CR34","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00467-008-0898-7","volume":"23","author":"JL Tobin","year":"2008","unstructured":"Tobin, J. L. & Beales, P. L. Restoration of renal function in zebrafish models of ciliopathies. Pediatr Nephrol \n                           23, 2095\u20132099, doi:10.1007\/s00467-008-0898-7 (2008).","journal-title":"Pediatr Nephrol"},{"key":"7300_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1681\/ASN.2015080906","volume":"28","author":"W Xu","year":"2017","unstructured":"Xu, W. et al. The Joubert Syndrome Protein Inpp5e Controls Ciliogenesis by Regulating Phosphoinositides at the Apical Membrane. J Am Soc Nephrol \n                           28, 118\u2013129, doi:10.1681\/ASN.2015080906 (2017).","journal-title":"J Am Soc Nephrol"},{"key":"7300_CR36","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1242\/dev.01772","volume":"132","author":"AG Kramer-Zucker","year":"2005","unstructured":"Kramer-Zucker, A. G. et al. Cilia-driven fluid flow in the zebrafish pronephros, brain and Kupffer\u2019s vesicle is required for normal organogenesis. Development \n                           132, 1907\u20131921, doi:10.1242\/dev.01772 (2005).","journal-title":"Development"},{"key":"7300_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.genet.39.073003.095931","volume":"39","author":"JL de Jong","year":"2005","unstructured":"de Jong, J. L. & Zon, L. I. Use of the zebrafish system to study primitive and definitive hematopoiesis. Annu Rev Genet \n                           39, 481\u2013501, doi:10.1146\/annurev.genet.39.073003.095931 (2005).","journal-title":"Annu Rev Genet"},{"key":"7300_CR38","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/dvdy.21581","volume":"237","author":"BA Mendelsohn","year":"2008","unstructured":"Mendelsohn, B. A., Kassebaum, B. L. & Gitlin, J. D. The zebrafish embryo as a dynamic model of anoxia tolerance. Dev Dyn \n                           237, 1780\u20131788, doi:10.1002\/dvdy.21581 (2008).","journal-title":"Dev Dyn"},{"key":"7300_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.molcel.2010.05.007","volume":"38","author":"AY Choo","year":"2010","unstructured":"Choo, A. Y. et al. Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol Cell \n                           38, 487\u2013499, doi:10.1016\/j.molcel.2010.05.007 (2010).","journal-title":"Mol Cell"},{"key":"7300_CR40","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/hmg\/ddn384","volume":"18","author":"LM DiBella","year":"2009","unstructured":"DiBella, L. M., Park, A. & Sun, Z. Zebrafish Tsc1 reveals functional interactions between the cilium and the TOR pathway. Hum Mol Genet \n                           18, 595\u2013606, doi:10.1093\/hmg\/ddn384 (2009).","journal-title":"Hum Mol Genet"},{"key":"7300_CR41","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00467-015-3134-2","volume":"31","author":"S De Rechter","year":"2016","unstructured":"De Rechter, S. et al. Autophagy in renal diseases. Pediatr Nephrol \n                           31, 737\u2013752, doi:10.1007\/s00467-015-3134-2 (2016).","journal-title":"Pediatr Nephrol"},{"key":"7300_CR42","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.kint.2016.04.014","volume":"90","author":"O Lenoir","year":"2016","unstructured":"Lenoir, O., Tharaux, P. L. & Huber, T. B. Autophagy in kidney disease and aging: lessons from rodent models. Kidney Int \n                           90, 950\u2013964, doi:10.1016\/j.kint.2016.04.014 (2016).","journal-title":"Kidney Int"},{"key":"7300_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/hmg\/ddx045","volume":"26","author":"P Zhu","year":"2017","unstructured":"Zhu, P., Sieben, C. J., Xu, X., Harris, P. C. & Lin, X. Autophagy activators suppress cystogenesis in an autosomal dominant polycystic kidney disease model. Hum Mol Genet \n                           26, 158\u2013172, doi:10.1093\/hmg\/ddw376 (2017).","journal-title":"Hum Mol Genet"},{"key":"7300_CR44","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1681\/ASN.2004090754","volume":"16","author":"IA Drummond","year":"2005","unstructured":"Drummond, I. A. Kidney development and disease in the zebrafish. J Am Soc Nephrol \n                           16, 299\u2013304, doi:10.1681\/ASN.2004090754 (2005).","journal-title":"J Am Soc Nephrol"},{"key":"7300_CR45","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1681\/ASN.2013040421","volume":"25","author":"CR Sussman","year":"2014","unstructured":"Sussman, C. R. et al. Phosphodiesterase 1A modulates cystogenesis in zebrafish. J Am Soc Nephrol \n                           25, 2222\u20132230, doi:10.1681\/ASN.2013040421 (2014).","journal-title":"J Am Soc Nephrol"},{"key":"7300_CR46","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1093\/hmg\/ddt556","volume":"23","author":"X Zhou","year":"2014","unstructured":"Zhou, X. et al. SIRT2 regulates ciliogenesis and contributes to abnormal centrosome amplification caused by loss of polycystin-1. Hum Mol Genet \n                           23, 1644\u20131655, doi:10.1093\/hmg\/ddt556 (2014).","journal-title":"Hum Mol Genet"},{"key":"7300_CR47","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1093\/ndt\/gfw058","volume":"31","author":"M Wu","year":"2016","unstructured":"Wu, M. et al. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor kappaB-induced inflammation. Nephrol Dial Transplant \n                           31, 1826\u20131834, doi:10.1093\/ndt\/gfw058 (2016).","journal-title":"Nephrol Dial Transplant"},{"key":"7300_CR48","doi-asserted-by":"publisher","first-page":"21819","DOI":"10.1073\/pnas.0911987106","volume":"106","author":"Y Cao","year":"2009","unstructured":"Cao, Y. et al. Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD models. Proc Natl Acad Sci USA \n                           106, 21819\u201321824, doi:10.1073\/pnas.0911987106 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"7300_CR49","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/zeb.2012.0825","volume":"10","author":"PS Tietz Bogert","year":"2013","unstructured":"Tietz Bogert, P. S. et al. The zebrafish as a model to study polycystic liver disease. Zebrafish \n                           10, 211\u2013217, doi:10.1089\/zeb.2012.0825 (2013).","journal-title":"Zebrafish"},{"key":"7300_CR50","doi-asserted-by":"publisher","first-page":"e1003053","DOI":"10.1371\/journal.pgen.1003053","volume":"8","author":"LF Menezes","year":"2012","unstructured":"Menezes, L. F. et al. Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4alpha as a disease modifier. PLoS Genet \n                           8, e1003053, doi:10.1371\/journal.pgen.1003053 (2012).","journal-title":"PLoS Genet"},{"key":"7300_CR51","doi-asserted-by":"publisher","first-page":"e39992","DOI":"10.1371\/journal.pone.0039992","volume":"7","author":"A Vasilyev","year":"2012","unstructured":"Vasilyev, A., Liu, Y., Hellman, N., Pathak, N. & Drummond, I. A. Mechanical stretch and PI3K signaling link cell migration and proliferation to coordinate epithelial tubule morphogenesis in the zebrafish pronephros. PLoS One \n                           7, e39992, doi:10.1371\/journal.pone.0039992 (2012).","journal-title":"PLoS One"},{"key":"7300_CR52","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ki.2012.446","volume":"83","author":"KI Swenson-Fields","year":"2013","unstructured":"Swenson-Fields, K. I. et al. Macrophages promote polycystic kidney disease progression. Kidney Int \n                           83, 855\u2013864, doi:10.1038\/ki.2012.446 (2013).","journal-title":"Kidney Int"},{"key":"7300_CR53","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.pharep.2013.11.008","volume":"66","author":"L Buldak","year":"2014","unstructured":"Buldak, L. et al. Metformin affects macrophages\u2019 phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes\/macrophages. Pharmacol Rep \n                           66, 418\u2013429, doi:10.1016\/j.pharep.2013.11.008 (2014).","journal-title":"Pharmacol Rep"},{"key":"7300_CR54","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.bbrc.2012.07.165","volume":"425","author":"SA Kim","year":"2012","unstructured":"Kim, S. A. & Choi, H. C. Metformin inhibits inflammatory response via AMPK-PTEN pathway in vascular smooth muscle cells. Biochem Biophys Res Commun \n                           425, 866\u2013872, doi:10.1016\/j.bbrc.2012.07.165 (2012).","journal-title":"Biochem Biophys Res Commun"},{"key":"7300_CR55","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","volume":"290","author":"DJ Klionsky","year":"2000","unstructured":"Klionsky, D. J. & Emr, S. D. Cell biology - Autophagy as a regulated pathway of cellular degradation. Science \n                           290, 1717\u20131721, doi:10.1126\/science.290.5497.1717 (2000).","journal-title":"Science"},{"key":"7300_CR56","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/emboj.2011.12","volume":"30","author":"DG Hardie","year":"2011","unstructured":"Hardie, D. G. AMPK and autophagy get connected. EMBO J \n                           30, 634\u2013635, doi:10.1038\/emboj.2011.12 (2011).","journal-title":"EMBO J"},{"key":"7300_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.semnephrol.2013.11.005","volume":"34","author":"K Ravichandran","year":"2014","unstructured":"Ravichandran, K. & Edelstein, C. L. Polycystic kidney disease: a case of suppressed autophagy? Semin Nephrol \n                           34, 27\u201333, doi:10.1016\/j.semnephrol.2013.11.005 (2014).","journal-title":"Semin Nephrol"},{"key":"7300_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2016.01.008","volume":"39","author":"O Pampliega","year":"2016","unstructured":"Pampliega, O. & Cuervo, A. M. Autophagy and primary cilia: dual interplay. Curr Opin Cell Biol \n                           39, 1\u20137, doi:10.1016\/j.ceb.2016.01.008 (2016).","journal-title":"Curr Opin Cell Biol"},{"key":"7300_CR59","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1038\/onc.2012.277","volume":"32","author":"N Chen","year":"2013","unstructured":"Chen, N., Eritja, N., Lock, R. & Debnath, J. Autophagy restricts proliferation driven by oncogenic phosphatidylinositol 3-kinase in three-dimensional culture. Oncogene \n                           32, 2543\u20132554, doi:10.1038\/onc.2012.277 (2013).","journal-title":"Oncogene"},{"key":"7300_CR60","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.ejca.2012.10.027","volume":"49","author":"J Yang","year":"2013","unstructured":"Yang, J., Kalogerou, M., Gallacher, J., Sampson, J. R. & Shen, M. H. Renal tumours in a Tsc1+\/\u2212 mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin. Eur J Cancer \n                           49, 1479\u20131490, doi:10.1016\/j.ejca.2012.10.027 (2013).","journal-title":"Eur J Cancer"},{"key":"7300_CR61","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","volume":"119","author":"AR Cameron","year":"2016","unstructured":"Cameron, A. R. et al. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status. Circ Res \n                           119, 652\u2013665, doi:10.1161\/CIRCRESAHA.116.308445 (2016).","journal-title":"Circ Res"},{"key":"7300_CR62","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ebiom.2016.01.027","volume":"5","author":"LF Menezes","year":"2016","unstructured":"Menezes, L. F., Lin, C. C., Zhou, F. & Germino, G. G. Fatty Acid Oxidation is Impaired in An Orthologous Mouse Model of Autosomal Dominant Polycystic Kidney Disease. EBioMedicine \n                           5, 183\u2013192, doi:10.1016\/j.ebiom.2016.01.027 (2016).","journal-title":"EBioMedicine"},{"key":"7300_CR63","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1681\/ASN.2015020132","volume":"27","author":"G Warner","year":"2016","unstructured":"Warner, G. et al. Food Restriction Ameliorates the Development of Polycystic Kidney Disease. J Am Soc Nephrol \n                           27, 1437\u20131447, doi:10.1681\/ASN.2015020132 (2016).","journal-title":"J Am Soc Nephrol"},{"key":"7300_CR64","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/ndt\/gft521","volume":"29","author":"I Rowe","year":"2014","unstructured":"Rowe, I. & Boletta, A. Defective metabolism in polycystic kidney disease: potential for therapy and open questions. Nephrol Dial Transplant \n                           29, 1480\u20131486, doi:10.1093\/ndt\/gft521 (2014).","journal-title":"Nephrol Dial Transplant"},{"key":"7300_CR65","unstructured":"Westerfield, M. The zebrafish book. A guide for the laboratory use of zebrafish (Danio rerio), 4th ed. University of Oregon Press, Eugene, OR (2000)."},{"key":"7300_CR66","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ydbio.2007.06.022","volume":"309","author":"B Perner","year":"2007","unstructured":"Perner, B., Englert, C. & Bollig, F. The Wilms tumor genes wt1a and wt1b control different steps during formation of the zebrafish pronephros. Dev Biol \n                           309, 87\u201396, doi:10.1016\/j.ydbio.2007.06.022 (2007).","journal-title":"Dev Biol"},{"key":"7300_CR67","doi-asserted-by":"publisher","first-page":"572","DOI":"10.4161\/auto.27649","volume":"10","author":"E Lee","year":"2014","unstructured":"Lee, E. et al. Autophagy is essential for cardiac morphogenesis during vertebrate development. Autophagy \n                           10, 572\u2013587, doi:10.4161\/auto.27649 (2014).","journal-title":"Autophagy"},{"key":"7300_CR68","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ydbio.2008.04.032","volume":"319","author":"SF Krens","year":"2008","unstructured":"Krens, S. F. et al. Distinct functions for ERK1 and ERK2 in cell migration processes during zebrafish gastrulation. Dev Biol \n                           319, 370\u2013383, doi:10.1016\/j.sydbio.2008.04.032 (2008).","journal-title":"Dev Biol"},{"key":"7300_CR69","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1242\/dmm.001016","volume":"2","author":"C Santoriello","year":"2009","unstructured":"Santoriello, C. et al. Expression of H-RASV12 in a zebrafish model of Costello syndrome causes cellular senescence in adult proliferating cells. Dis Model Mech \n                           2, 56\u201367, doi:10.1242\/dmm.001016 (2009).","journal-title":"Dis Model Mech"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07300-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07300-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07300-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:49:26Z","timestamp":1671781766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07300-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,2]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["7300"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-07300-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,2]]},"assertion":[{"value":"25 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7161"}}